Aptimmune Biologics, Inc. — Form D/A
Aptimmune Biologics, Inc. of CHAMPAIGN, IL, a company, filed a Form D amendment with the SEC on 2016-03-24. The offering totals $3.3M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-03-24
- Form: D/A
- Accession: 0001648213-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $2.4M
- Remaining: $830K
- Minimum investment: $1
- Investors: 8
- Date of first sale: 2015-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-243862
Issuer
- Name: Aptimmune Biologics, Inc.
- CIK: 0001648213
- Entity type: Corporation
- Jurisdiction: ILLINOIS
- Address: 60 HAZELWOOD DRIVE, CHAMPAIGN, IL, 61820
- Phone: 217-377-8866
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Aaron Gilbertie | Director | West Lafayette, IN |
| Aaron Gilbertie | Executive Officer | West Lafayette, IN |
| Gary Durack | Director | Champaign, IL |
| Paul Olivo | Director | Champaign, IL |
| Robert Easter | Director | Champaign, IL |
| Federico Zuckermann | Director | Champaign, IL |
| Federico Zuckermann | Executive Officer | Champaign, IL |
Other filings by this issuer (2)
More